In vitro activities of fourteen antimicrobial agents against obligately anaerobic bacteria

International Journal of Antimicrobial Agents

Volumn 16, Issue 3, 2000, Pages 225-232

  Schaumann, Reiner ^a   Ackermann, Grit ^a   Pless, Baerbel ^a   Claros, Marina C ^a   Goldstein, Ellie J C ^b   Rodloff, Arne C ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b R M ALDEN RESEARCH LABORATORY   (United States)

Author keywords

Antimicrobial agents; Broth microdilution technique; MIC; Obligately anaerobic bacteria

Indexed keywords

AMOXICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLAVULANIC ACID; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GATIFLOXACIN; IMIPENEM; LEVOFLOXACIN; MEROPENEM; METRONIDAZOLE; MOXIFLOXACIN; PENICILLIN DERIVATIVE; TROVAFLOXACIN;

ANAEROBIC BACTERIUM; ARTICLE; BACTERIUM ISOLATE; BACTEROIDES; BACTEROIDES CACCAE; BACTEROIDES DISTASONIS; BACTEROIDES FRAGILIS; BACTEROIDES OVATUS; BACTEROIDES THETAIOTAOMICRON; BACTEROIDES VULGATUS; CLOSTRIDIUM; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SCREENING; FUSOBACTERIUM; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PEPTOSTREPTOCOCCUS; PREVOTELLA; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANTI-BACTERIAL AGENTS; BACTERIA, ANAEROBIC; HUMANS; MICROBIAL SENSITIVITY TESTS;

EID: 0033692529     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(00)00186-2     Document Type: Article

References (15)

1. Comparative in vitro activities of a new quinolone, WIN 57 273, and piperacillin plus tazobactam against anaerobic bacteria
2. Characterization of indole-negative Bacteroides fragilis group species with use of polymerase chain reaction fingerprinting and resistance profiles
3. Characteristics of Fusobacterium ulcerans, a new and unusual species compared to Fusobacterium varium and Fusobacterium mortiferum
4. In vitro activities of gatifloxacin, two other quinolones, and five nonquinolone antimicrobials against obligately anaerobic bacteria
5. Comparative in vitro activities of trovafloxacin (CP 99 219) and other antimicrobials against clinically significant anaerobes
6. Comparison of the in vitro activities of Bay 12-8039, a new quinolone, and other antimicrobials against clinically important anaerobes
7. Activities of gatifloxacin compared to those of seven other agents against anaerobic organisms
8. Antianaerobic activity of the ketolide RU 64 004 compared to activities of four macrolides, five beta-lactams, clindamycin, and metronidazole
9. In vitro activity of gemifloxacin (SB 265 805) against anaerobes
10. Bay 12-8039, a new 8-methoxy-quinolone: Comparative in vitro activity with nine other antimicrobials against anaerobic bacteria
11. In vitro activities of trovafloxacin against 557 strains of anaerobic bacteria
12. Stability of imipenem in Mueller-Hinton agar stored at 4°C
13. German multicentre study on the in vitro susceptibility of Bacteroides species